Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.
Press releases published on June 5, 2025
Roquette nomme Thierry Fournier au poste de Directeur Général
GlobeNewswire
·
June 5, 2025
Roquette nomme Thierry Fournier au poste de Directeur Général Lille, France, 5 juin 2025 - Roquette, un leader mondial des ingrédients d’origine végétale et des excipients pharmaceutiques destinés aux secteurs de la santé, de la nutrition et de la bio- …
The Foundation for Sarcoidosis Research and American Thoracic Society Announce Dr. Mark Mallozzi as the New FSR/ATS Partner Grant Awardee
GlobeNewswire
·
June 5, 2025
CHICAGO, June 05, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) and the American Thoracic Society (ATS) are pleased to announce that Mark Mallozzi, MD, MPH has been selected to receive the 2025 ATS/FSR Partner Grant, awarded to …
Dilated Cardiomyopathy Market Witnesses Robust Growth During the Study Period (2020–2034) Amid Advancements in Cardiovascular Therapies | DelveInsight
GlobeNewswire
·
June 5, 2025
New York, USA, June 05, 2025 (GLOBE NEWSWIRE) -- Dilated Cardiomyopathy Market Witnesses Robust Growth During the Study Period (2020–2034) Amid Advancements in Cardiovascular Therapies | DelveInsight The dilated cardiomyopathy market is experiencing …
Global Antidote Market to Cross the USD 4 Billion Mark by 2032 | DelveInsight
GlobeNewswire
·
June 5, 2025
New York, USA, June 05, 2025 (GLOBE NEWSWIRE) -- Global Antidote Market to Cross the USD 4 Billion Mark by 2032 | DelveInsight The antidote market is witnessing substantial growth, largely propelled by the growing incidence of poisoning, drug overdoses, …
Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology
GlobeNewswire
·
June 5, 2025
PONTE VEDRA, Fla., June 05, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities …
Scilex Holding Company Announces Publication on GLOPERBA® Dosing Adjustments in Peer-Review Journal
GlobeNewswire
·
June 5, 2025
PALO ALTO, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the …
Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ®
GlobeNewswire
·
June 5, 2025
IXCHIQ® was well tolerated by children aged one to eleven years regardless of the dose or previous chikungunya infection (CHIKV) Antibody levels remained high after six months in both dose groups, although more robust with the full dose Six-month data …
Valneva annonce des résultats positifs de Phase 2 à six mois sur la persistance des anticorps et l’innocuité de son vaccin à dose unique contre le chikungunya IXCHIQ® chez les enfants
GlobeNewswire
·
June 5, 2025
IXCHIQ® a été bien toléré par les enfants âgés d’un à onze ans indépendamment de la dose de vaccin reçue (dose complète ou demi-dose) ou d’une précédente infection au virus du chikungunya Les niveaux d’anticorps demeurent élevés après six mois dans les …
Merus N.V. gibt Preis für öffentliches Angebot von Stammaktien bekannt
GlobeNewswire
·
June 5, 2025
UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts, June 05, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) („Merus“, das „Unternehmen“, „wir“ und „unser“), ein Onkologieunternehmen, das innovative, multispezifische Antikörper in voller Länge und …
Merus N.V. annonce la fixation du prix de l’offre publique d’actions ordinaires
GlobeNewswire
·
June 5, 2025
UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachusetts, 05 juin 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), ci-après « Merus », la « Société », « nous » ou « notre/nos », une société spécialisée dans l’oncologie développant des anticorps …
CORRECTION - Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority
GlobeNewswire
·
June 5, 2025
RA'ANANA, Israel, June 05, 2025 (GLOBE NEWSWIRE) -- RA'ANANA, Israel, June 5, 2025 -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira," “Inspira Technologies,” or the "Company"), a pioneer in innovative life-support and diagnostic …
Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
GlobeNewswire
·
June 5, 2025
SARASOTA, FL, June 05, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced that its Board of Directors …
Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority
GlobeNewswire
·
June 5, 2025
RA'ANANA, Israel, June 05, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira," “Inspira Technologies,” or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced that it has …
Outset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
June 5, 2025
SAN JOSE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that management will …
Telehealth Market & Telemedicine Market to Hit US$180.86 Billion by 2030 with 11.5% CAGR | MarketsandMarkets™
GlobeNewswire
·
June 5, 2025
Delray Beach, FL, June 05, 2025 (GLOBE NEWSWIRE) -- The Telehealth Market …
Artelo’s Fatty Acid Binding Protein 5 Inhibitor, ART26.12, Compares Favorably to Naproxen in an Osteoarthritis Pain Study
GlobeNewswire
·
June 5, 2025
SOLANA BEACH, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, …
Doheny Eye Institute Welcomes Emma Lessieur-Contreras, MD, PhD, as Principal Investigator
GlobeNewswire
·
June 5, 2025
PASADENA, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Doheny Eye Institute, one of the nation’s leading vision research institutions for more than 75 years, is adding to its panel of remarkable vision scientists with the appointment of Emma Lessieur- …
Precision Optics Expands Facilities to Meet Growing Backlog
GlobeNewswire
·
June 5, 2025
Company signs lease to move corporate offices and engineering development to Littleton, MA Move allows for expansion of production capabilities in Gardner, MA to meet increased backlog GARDNER, Mass. and LITTLETON, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- …
Cellectar Biosciences Enters into Common Stock Agreements to Raise $2.5 Million Priced at Market Under Nasdaq Rules
GlobeNewswire
·
June 5, 2025
FLORHAM PARK, N.J., June 05, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced the entry into …
SELLAS Life Sciences Expands Scientific Advisory Board with Addition of Two World-Renowned Hematology and Oncology Experts
GlobeNewswire
·
June 5, 2025
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …